Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acceleron Pharma Inc (NASDAQ:XLRN)

31.48
Delayed Data
As of Dec 08
 +0.52 / +1.68%
Today’s Change
22.67
Today|||52-Week Range
50.86
-35.44%
Year-to-Date

Today’s Trading

Previous close30.96
Today’s open31.00
Day’s range30.33 - 31.74
Volume404,844
Average volume (3 months)321,856
Market cap$1.2B
Dividend yield--
Data as of 4:00pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)-17.71%
Earnings growth (this year)+17.27%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+23.68%
P/E ratioNM
Price/Sales89.73
Price/Book9.44

Competitors

 Today’s
change
Today’s
% change
AMAGAMAG Pharmaceuticals...+0.50+1.50%
CHRSCoherus BioSciences ...+0.35+1.27%
MNTAMomenta Pharmaceutic...+0.20+1.40%
AVXSAveXis Inc+2.38+4.51%
Data as of 4:00pm ET, 12/08/2016

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$18.1M
Annual profit (last year)-$63.9M
Net profit margin-353.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Habib J. Dable
Chief Operating Officer &
Executive Vice President
Steven D. Ertel
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs